Trimas Corp Q4 FY2025 Earnings Call

Ladies and gentlemen, good morning, and welcome to the TriMas Corporation Fourth Quarter and Full Year 2025 Earnings Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, TriMas Corporation's VP, Investor Relations, Sherry Lauderback. Please go ahead.

Thank you, and welcome to TriMas Corporation's Fourth Quarter and Full Year 2025 Earnings Call. Joining me today are Thomas Snyder, TriMas' President and CEO; and Paul Swart, our Chief Financial Officer. We'll begin with prepared remarks covering our fourth quarter and full year results, followed by our expectations for 2026 and the future of TriMas, after which we will open the call for questions from our analysts. To help you follow along with today's discussion, both the press release and our presentation are available on our website at trimas.com under the Investors section. A replay of this call will also be available later today by dialing (877) 660-6853 and using the meeting ID of 1375-8505. Before we begin, I'd like to remind everyone that today's comments may include forward-looking statements, which are inherently subject to various risks and uncertainties. Please refer to our most recent Form 10-K and 10-Q filings for a discussion of the factors that could cause our results to differ from those anticipated in any forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, except as required by law. We also encourage you to visit our website where more information is available. In addition, please refer to the appendix of our press release or presentation for reconciliations of GAAP to non-GAAP financial measures. Throughout today's call, our discussion of financial results will be on an adjusted basis, excluding the impact of special items. At this point, I'll turn the call over to Tom. Tom?

Thank you, Sherry. Good morning, everyone, and thank you for joining us today. Before we discuss our quarterly and year-end results, I want to take a moment to reflect on 2025, a truly transitional year for TriMas. This is not the same company you saw a year ago. Over the past eight months since I've joined TriMas, we have sharpened our strategic focus, strengthened our leadership team and begun rebuilding the foundation necessary to deliver stronger and more consistent performance going forward. I'd also like to formally introduce our new CFO, Paul Swart, who joined us in mid-December. Paul brings more than 25 years of financial and operational leadership experience, including two decades here at TriMas across corporate and operational finance, accounting and business planning. His deep familiarity with our business and his recent experiences leading transformation efforts make him a tremendous addition to our leadership team and an exceptional partner as we enter this next phase. We are excited to have him back. Welcome back, Paul. Over the past few months, we've refreshed our management approach, clarified roles and accountability and elevated decision-making speed and execution. This has enabled us to focus our energy on the areas that matter most, serving our customers, improving operations and developing our people and driving performance. We've made meaningful progress in elevating operational excellence and strengthening our commercial execution. In the latter part of 2025, we completed approximately 100 customer interviews across 10 countries as part of our voice of the customer initiative, giving us clear insights into customer expectations and where we must raise the bar to win with our customers. These insights are driving changes in how we organize and engage with customers so that we are more aligned with their needs and more connected in our day-to-day interactions. We also launched a structured global operational excellence program, a company-wide operating system rooted in Lean Six Sigma principles. This program is designed to drive continuous improvement, enhance efficiency and increase standardization across our footprint with a focus on safety, quality, delivery and cost. We are encouraged by the initial launch within our packaging business at two larger locations and look forward to rolling out the program to more sites in 2026. These operational and cultural changes are creating more unified practices across the organization, strengthening the foundation of data-driven management and elevating accountability among our teams. Building upon this increased accountability and better visibility into our KPIs, we also restructured our 2026 incentive program to reinforce a disciplined pay-for-performance culture that rewards results and aligns the entire organization on its true north. As I've traveled to our locations over the past several months, I've seen firsthand the impact of these efforts as we are a company with strong capabilities powered by talented people who are deeply committed to delivering value for our customers and shareholders. At the same time, those visits have highlighted clear opportunities for continuous improvement, areas where we can evolve, innovate and further strengthen our foundation for the future. Taken together, these actions underscore a simple point, TriMas today is becoming more focused, more agile and better positioned to deliver. With that foundation in place, let's turn to Slide 4 to review several key actions underway that will further transform TriMas and drive the next phase of improvement across the organization. First, we continue to make solid progress toward completing the divestiture of TriMas Aerospace, which we announced in early December. The transaction remains on track to close in mid- to late March. As previously communicated, the purchase price is approximately $1.45 billion in cash, which we expect will generate approximately $1.2 billion in net after-tax proceeds. As a result of the pending sale, TriMas Aerospace is now reported as discontinued operations beginning with these quarterly results. You'll also notice that we provided additional disclosure to help you interpret the results. We've included both total company performance and the breakout between continuing and discontinued operations where practicable. And to ensure comparability, we have recast certain historical periods to reflect the planned sale of TriMas Aerospace. That recast information will be available in the Form 8-K we are filing today. Following the close, TriMas will operate with two reporting segments: our Packaging segment and our Specialty Products segment. The divestiture positions TriMas as a more focused company and the significant proceeds provide us with meaningful flexibility as we execute our capital deployment priorities, including share repurchases, investing in organic growth initiatives, pursuing targeted acquisitions and maintaining our balance sheet. Let me now cover how we are approaching capital deployment as we move into the next chapter. Our priorities remain consistent, reinvesting in the business, pursuing selective acquisitions, particularly in the Packaging and Life Science space and returning capital to shareholders as appropriate. To support a more disciplined and strategic approach to M&A, we have established a strategic investment committee that brings sharper focus and rigor to evaluating opportunities aligned with our long-term vision. Since announcing the divestiture, we have repurchased more than three million shares for approximately $100 million. And as announced earlier today, we increased our remaining share repurchase authorization back to $150 million. The Board will continue to assess potential increases to the company's existing share repurchase authorization as we move forward. As we deploy capital, we expect to repurchase additional shares while also planning to pay down the revolver borrowings associated with the prior buybacks. In parallel with these strategic actions and a smaller, more focused organization, we have also reshaped our structure to operate more efficiently and better serve our customers. At the end of January, we implemented a company-wide realignment to streamline operations, including integrating certain corporate and business functions to simplify the structure, eliminate duplication and improve execution. Savings from the initiatives we have completed are expected to ramp up throughout the year, generating over $10 million of cost reductions in 2026 and more than $15 million on an annualized basis. In addition, within TriMas Packaging, we are restructuring the commercial and operational model to break down silos, accelerate decision-making and to strengthen customer engagement and responsiveness. This transformation is supported by several initiatives, including brand unification, expanded operational excellence programs, upgraded systems and continued optimization of our manufacturing footprint. Collectively, these actions are strengthening TriMas' operational model, enhancing customer satisfaction and positioning the company for sustainable long-term value creation. As we advance this work, I'm also drawing on several decades of personal experience operating in highly competitive environments where two principles ultimately determined who won: relentless cost discipline and unwavering focus on the customer. Those disciplines are more important today than ever as we compete to win in the marketplace. As I look at the transformation underway, I feel strongly that this is where I can help us create real value by instilling a sharper cost mindset across the organization and elevating our focus on serving customers better than our competitors. Shifting gears, let's turn to our full year and fourth quarter performance. Despite all the transition and change throughout 2025, we delivered full year and fourth quarter results in line with our expectations. Total company adjusted earnings per share for the year was $2.09, towards the upper end of our provided guidance range of $2.02 to $2.12, which had already been raised earlier in the year. I'm very proud of how our teams executed during this period of significant transformation. And with that, I'll now turn the call over to Paul, who can walk us through the financial results in more detail. Paul?

Thank you, Tom, and good morning, everyone. I'm thrilled to be back at TriMas and lead the company along with our dedicated group of employees as we embark on the next chapter in our history. Let's pick up from where Tom left off with a financial overview on Slide 5, which presents our fourth quarter and full year results. This slide outlines our total company results before accounting for the reclassification of Aerospace to discontinued operations to align with our most recent outlook. For the fourth quarter, TriMas reported total net sales of $256 million, representing a 12.5% increase from the previous year. Organic growth in each of our segments was over 9%, bolstered by the contribution from our 2025 acquisition in Germany and some positive effects from currency exchange. However, these gains were partially offset by the impact of the Arrow Engine divestiture, which affected us in 2024 but was only involved for one month in 2025. On the profitability front, our segment operating profit for the fourth quarter rose more than 21% to $33 million, with margins expanding by 90 basis points, fueled by higher sales and effective operational execution. Adjusted EPS for the fourth quarter decreased by $0.03 year-over-year due to incentive compensation timing and elevated foreign currency exchange fluctuations in 2025 compared to 2024. For the full year, our total company net sales surpassed $1 billion, marking a year-over-year increase of 12.7%, driven primarily by organic sales growth in each segment, particularly in Aerospace. The February Aerospace acquisition in Germany contributed $23 million, more than offsetting the $18 million impact from the Arrow Engine divestiture. Adjusted segment operating profit increased by over 30% to $149 million, reflecting a 200 basis point year-over-year improvement due to higher sales and operational enhancements throughout the year. Additionally, as Tom noted, adjusted EPS rose by $0.44 year-over-year, or 27%, to $2.09, positioning us at the higher end of our guidance range of $2.02 to $2.12. Overall, we're pleased with our growth and margin expansion in 2025, which exceeded our original expectations, especially as Aerospace-specific growth strengthened its financial profile and will allow us to realize the value created by our team once the deal closes in the upcoming weeks. Turning to Slide 6, I'll discuss our cash flow and balance sheet. We achieved robust cash performance in 2025, producing fourth quarter and full year free cash flow of $43 million and $87 million, respectively, both more than double the figures from the prior year. This improvement is attributed to stronger operating results and disciplined working capital management. The strong cash flow enabled us to fund the $38 million acquisition price in Aerospace and buy back over $100 million in stock during 2025, all while only increasing our net debt by $64 million to $439 million. In light of the Aerospace divestiture announcement, we repurchased more than three million shares for just over $100 million, lowering our year-end outstanding share count to 37.6 million. We conducted these repurchases thoughtfully, taking on a controlled level of net leverage in advance of certain outcomes while seizing the opportunity to buy back shares that did not represent the company's true value. The share repurchase authorization announced today, returning to $150 million, provides us with additional flexibility moving forward, especially post-deal closure. At year-end, our total debt consisted of $400 million in bonds due in 2029, along with around $70 million in revolving borrowings. Our net leverage remained steady from the previous year-end at 2.6x but increased from 2.2x in the third quarter due to financing most of the share repurchases through the revolver. We anticipate receiving approximately $1.2 billion in net after-tax proceeds from the sale of TriMas Aerospace, and upon receipt, we plan to pay off any outstanding amounts on the revolver. We intend to invest the remaining roughly $1.1 billion in high-quality interest-bearing accounts while we await redeployment. Assuming the deal closes in late March, we project this balance may yield up to $30 million in cash interest over the last three quarters of the year, depending on the timing, amount of cash redeployed, and the actual interest rate earned. Now let’s turn to business performance and discuss Packaging on Slide 7. As anticipated, the fourth quarter was mixed, consistent with what we've handled all year. Sales increased by 5% year-over-year, with organic sales rising by 2.4%. This growth was driven by strong demand in industrial and life sciences products, but was somewhat offset by weaker demand in food and beverage applications, particularly in flexibles and closures. Operating profit of $15 million dropped about 5% year-over-year, and margins stood at 11.6%, lower than both the previous year and the first nine months of 2025, due to a less favorable mix and the typical seasonal patterns of Q4. For the full year, Packaging achieved 4% organic growth and maintained nearly flat margins, with an operating profit of $71 million and a 13.3% margin, which we consider a solid performance given the ongoing macroeconomic challenges, tariffs, and demand uncertainties across various end markets. Looking ahead to 2026, we expect continued momentum with sales growth between 3% to 6% and margin improvement to 14% to 15%, as cost-cutting measures initiated previously take effect. We anticipate sales and profit growth in Q1 will be at the lower end of our full-year ranges, and we will keep focusing on enhancing operational and commercial execution to improve profitability, efficiency, and customer satisfaction. Overall, the business concluded the year with a robust foundation and clear drivers for profit enhancement as we enter 2026. Now, moving to Slide 8, I will review our Specialty Products segment. Norris Cylinder, the remaining business in this segment, had a solid year, although results are less apparent due to the Arrow Engine sale, which finalized in January 2025. In the fourth quarter, Norris achieved nearly 14% year-over-year sales growth, despite total segment sales declining 1.4% because of the Arrow Engine divestiture affecting the results. However, profitability saw significant improvement. Operating profit and margins doubled year-over-year, reaching a margin of 6.5%, driven by earlier cost restructuring efforts. For the full year, Norris Cylinder recorded 9.5% sales growth and nearly doubled its operating profit, contributing $5.4 million in operating profit with a 4.9% margin. While this performance was positive, it only partially compensated for the loss of profit from Arrow, as it was part of Specialty Products for all of 2024 but only one month in 2025. In looking forward, we foresee continued growth within the range of 3% to 6% in sales for 2026, with operating profit margins expected between 8% to 10%. Q1 is projected to trend toward the upper end of the sales range with margins rising from 2025 levels into the 8% to 10% range, bolstered by stronger sales intake, our U.S.-based positioning, and further leveraging the prior cost restructuring actions. Despite the challenges from the Arrow Engine divestiture, Specialty Products begins 2026 with improved profitability fundamentals and the potential for further enhancements. Finally, let’s examine our Aerospace segment, which is now classified as discontinued operations and assets held for sale on Slide 9. This was a remarkable year for the Aerospace business, delivering record results that significantly contributed to our strong valuation in the upcoming sale. Fourth quarter sales grew by 29% compared to the previous year, driven by enhanced output, commercial dynamics, and nearly 10% growth from acquisitions. Operating profit surged more than 50%, with margins expanding by 240 basis points, supported by healthy sales leverage and sustained operational excellence. For the full year, sales rose nearly 35%, with an improvement of over 600 basis points in operating margin, reflecting consistent performance across the organization. The team has excelled in generating value for TriMas and its shareholders throughout 2025. A big thank you to the team for their contributions this year. Given that the transaction is anticipated to close in the first quarter and Aerospace's financial results are included in discontinued operations, we will not be providing forward guidance for this segment. To conclude the financial review, despite a year filled with transitions and macroeconomic hurdles, our results aligned with our expectations, establishing a solid base to enhance the position of the newly focused TriMas going forward. After examining the overall company results, we believed it was vital to provide clarity on the remaining TriMas after the Aerospace sale on Slide 10. This slide displays the continuing business segments and consolidated metrics for 2025, as well as our initial thoughts on 2026 and beyond. Net sales were $645 million in 2025, with an operating profit of $34 million, adjusted EBITDA of $79 million, and an EPS of $0.55. As Tom has previously mentioned, the remaining TriMas possesses several pathways to streamline, integrate, and optimize costs, while simplifying and reinforcing commercial strategies. Actions have already been taken during the second half of 2025 and into 2026, which we expect to substantially enhance our financial performance this year, with benefits to be realized in future periods. We are also set to evaluate more opportunities as new IT systems and processes allow for further improvements. Additionally, the oversight functions and costs of a company generating over $1 billion in revenue differ greatly from those for a focused entity with two segments. Changes have already been implemented to centralize and integrate necessary functions to simplify operations and reduce costs. There are also further opportunities for cost efficiencies after the Aerospace transition support is finalized. In 2025, TriMas operated at a 12% adjusted EBITDA margin, which we believe is significantly lower than the long-term potential of this current set of businesses, even before reinvesting any proceeds from Aerospace to enhance the portfolio further. As Tom will highlight shortly, we expect 2026 to be a strong initial step in a multi-year program aimed at continuously improving towards these objectives, and we will keep you updated on our progress along the way.

Thank you, Paul. I want to take a moment to discuss what the future holds for TriMas as we become a more focused company, starting with our outlook for 2026. With the TriMas Aerospace sale anticipated to close in mid- to late March, my comments today will center on our ongoing operations and the key assumptions informing our expectations for 2026. For the entire year, we project sales growth between 3% and 6% compared to our 2025 baseline of around $646 million. We also anticipate an improvement of over 300 basis points in adjusted operating margins, fueled by continued operational excellence in both Packaging and Specialty Products, as well as the full-year impact of cost-reduction and organizational realignment initiatives already in progress, including an expected decrease in corporate cash expenses of at least $10 million in 2026 compared to 2025. Considering the scale of these cost-saving measures and the timing to achieve their full effects, we expect the first quarter of 2026 to be our weakest in terms of margins and earnings per share. Although we forecast sales growth of 3% to 6% in Q1, we project adjusted operating margins to improve by just over 100 basis points compared to Q1 2025, and sequentially, it would reflect an improvement of more than 400 basis points from Q4 2025. We've also shared a few additional assumptions for Q1 given the substantial changes occurring within the company. Throughout the first quarter and the rest of the year, we expect year-over-year advancements in sales, earnings, and earnings per share in each quarter as savings accumulate and operational performance enhances. Importantly, today's expectations do not factor in any reinvestment of the TriMas Aerospace sale proceeds. Lastly, due to the pending sale of TriMas Aerospace, we will provide guidance for full-year earnings per share during our Q1 2026 earnings call in April, after the transaction closes. Before we proceed to Q&A, I want to emphasize why we're so optimistic about TriMas's future and the company we are evolving into. With the nearing completion of the Aerospace divestiture, TriMas is transforming into a more focused and agile organization centered around businesses with solid market positions and significant opportunities for value creation. We now have a strong foundation to build upon as we continue to transform the company. Our identity is clear: we are a global provider of high-value dispensing, closure, and life sciences solutions underpinned by deep technical expertise, established customer partnerships, and a flexible global manufacturing footprint. Our market exposure is diverse, and our teams foster a culture of innovation and operational excellence that delivers sustainable, high-quality solutions. Crucially, our customer-first approach, supported by a unified sales team and integrated solutions, distinguishes us. We've streamlined the organization to enhance speed and responsiveness. Our innovation pipeline is closely aligned with customer needs, and we're leveraging technology and operational excellence to improve quality, drive down costs, and accelerate market entry. Our strategy focuses on boosting growth in higher-value, higher-margin applications, particularly in Life Sciences and segments of our packaging business where our capabilities and customer access present substantial opportunities for expansion. Additionally, we will have the financial flexibility to continue investing in our future. Proceeds from the aerospace sale will allow us to fund growth, pursue strategic acquisitions, maintain a solid balance sheet, and return capital to shareholders. Together, the new TriMas represents a focused portfolio with enhanced capabilities, a stronger foundation, and considerable future opportunities. As we look ahead, TriMas has numerous avenues available to boost growth across sales, earnings, and long-term value creation. With a stronger operational base and significant capital to deploy, we are well-positioned to advance our strategy, deepen customer relationships, and invest in high-value opportunities across our markets. Our teams are motivated, and I am very excited about TriMas's future. Thank you, and now I’ll turn it back over to Sherry.

Thanks, Tom. At this point, we would like to open the call to questions from our analysts.

We take the first question from the line of Ken Newman from KeyBanc Capital Markets.

Paul, it's great to hear from you again. Congrats on coming back. So maybe to my first one, I know there's a lot of moving pieces, so first, thanks for all the increased transparency around all that. I think it helps to get an apples-to-apples look. I'm curious if, first, could you just help us how to think about the cadence of margin improvement as we move beyond the first quarter? Are there things that are easier to kind of get done in the second and third quarters? Is there any seasonality we should kind of think about? Or is this really more of a linear progression up as we move through the year?

Sure. As we look ahead, we anticipate an increase in savings from our $10 million cost-saving initiatives along with other efforts throughout the year. It's important to remember that the second and third quarters are typically our strongest sales periods, so we expect an increase in sales from the first to the second quarter, followed by higher margins in the second to third quarters. While either the second or third quarter could be our top sales quarter, they are generally the two highest. The fourth quarter usually sees a decline in sales, and we also expect margins to decrease from the third to the fourth quarter, although they will still be significantly better than in the first quarter.

Okay. That's very helpful. I appreciate that. And then within Packaging, obviously, you're forecasting or guiding to margin improvement there. I know there was a mix headwind this quarter that was a little higher than I was expecting on my apples-to-apples model. Is there a way to bridge how you think about the margin improvement within Packaging that's being driven by either cost-out efficiencies versus better mix or market demand?

Yes. I'll give it a try and then Paul can add anything I might miss. From a strategic standpoint in packaging, we have seen a lot of improvements. Some of this stems from consolidating our organizational efforts, as we previously had a fragmented approach in certain areas of the company. This consolidation was part of our initiative in January. Additionally, we have operational improvements throughout the year that will continue to benefit us. While Q4 faced some challenges and differences in product mix, I don’t see it all negatively. On the sales side in Q4, we had significantly more tooling sales than usual, which typically convert at a lower rate than our regular products. However, the positive aspect is that this lays the groundwork for key initiatives and projects we are working on that are set to launch in 2026, which I am very excited about. So, overall, I don't view the situation negatively.

Yes. And from a balancing perspective, I think it's probably pretty well weighted between the two of them in terms of how much read-through is from cost savings actions versus how much is just going back to a normal product sales versus tooling sales as we move into first quarter. So I mean, I think it's pretty balanced between the two. It's not that we're expecting a tremendous difference other than the tooling sales that we have visibility to in Q4, not repeating at the same level.

Got it. Okay. Maybe I could just squeeze one more in. It was good to see another increase in the share repurchase authorization today. Tom, you also talked about this new investment community to analyze potential deals. First, I guess, how aggressive can you get on the repurchase authorization in the coming quarters? And second, as it relates to potential acquisitions, is there a way to help us think about what the pipeline looks like today and how quickly you think you could go after a deal within some of those higher mix, call it, life science type of targets?

Yes. We're focusing on understanding and exploring actionable opportunities, but first, we need to finalize our current transaction. Once that is complete, we'll provide a clearer outlook in our Q1 call, including insights on capital redeployment. Currently, it's difficult to offer specifics, but we are optimistic about our Life Science business and see growth potential there, along with other high-value opportunities within our operations. I wish I could share more details, but that's the situation for now. Regarding the share buyback, we'll clarify that as we approach the first quarter. We are reauthorizing an additional $150 million and will assess our next steps as part of our overall strategy, providing further insights in the future.

The next question comes from the line of Hamed Khorsand from BWS Financial.

Is there anything that could prevent the closing of the deal in Q2? Are you expecting a specific event for the closing process to proceed?

So there are regulatory processes, which obviously we don't control that are still underway based on everything we're aware of at this point. They're going through their normal course. And that's why we're projecting that if they are through when we expect them to be through based on typical days, that's why we're comfortable talking about the back half of March as the expected close date. So nothing we're aware of that would change that outcome today.

Okay. And then in the Packaging segment, is there any particular end market or geography that you're expecting to outperform this year compared to what your guidance is?

We are optimistic about several markets due to our extensive presence in various locations, which positions us well for upcoming opportunities. We anticipate growth in the life sciences sector that will positively impact our future performance. Our industrial business is also expected to grow due to changes in regulations where we maintain a strong market position. The beauty and personal care sector shows promising growth globally, and the markets we operate in are performing well, keeping us optimistic in this area. We foresee some recovery in the food and beverage sector this year compared to last, which was less favorable. We are projecting low to mid-digit recoveries in that market. Additionally, we have significant expertise in technologies, particularly in Europe, regarding beverage products that will be required to adopt new technologies in the coming 18 months. Overall, these are the major markets we are focusing on and what we expect in the near future.

Okay. And is any of that outlook that you just described because of the benefits of the cost cutting and the integration of the brands?

No. No. I mean what you're talking about is product specific. So it's really not as a result of the cost cutting or realignment, although I do think that inherent in that guidance is what Tom talked about related to our sales structure and our commercial strategy.

So I thought you there's more coming in your question, that's why I paused there. So the way that we're going to market, I think we're going to be more successful in being able to achieve growth in these particular areas. And my expectation is that we should be able to beat the market. I mean that's when I talked about earlier winning in the marketplace and beating the competition. The intent here is that we're going to be a low-cost, nimble organization that has quicker response times and with innovative products that meet the needs in the market. And we have a sales approach now that used to be a bit cumbersome. And so it was a duplication of sales across different product lines. What we heard through our voice of the customer survey is that we want a team, a person, a lead to talk to us about opportunities in our particular markets before we were tripping over ourselves. And so I think that's just another example of how we can bring efficiency to the commercial process. And if we can execute against everything that I've just said, we're going to be able to be more efficient, and we should be able to beat the market numbers from what I just talked about, so that's one of the areas that has me really excited.

Ladies and gentlemen, as there are no further questions from the participants, I now hand the conference over to the management for their closing comments.

Once again, we'd like to thank you for joining us today and for your continued interest in TriMas. We appreciate your ongoing support, and we look forward to updating you on our progress next quarter. Thank you.

Thank you.

Thank you. Ladies and gentlemen, the conference of TriMas Corporation has now concluded. Thank you for your participation. You may now disconnect your lines.